Inactive Instrument
NicOx SA Share Price Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.37Cr 3.93Cr 3.16Cr 2.89Cr 5.45Cr 375.04Cr 5.5Cr 37Cr 15Cr 189.22Cr 15Cr 14Cr 626.62Cr | P/E 2026 * |
-5.46x | P/E 2027 * | 38.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.37Cr 3.93Cr 3.16Cr 2.89Cr 5.45Cr 375.04Cr 5.5Cr 37Cr 15Cr 189.22Cr 15Cr 14Cr 626.62Cr | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | 3.37x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 3.93Cr | |
| +3.88% | +15.37% | +82.79% | +41.49% | 37TCr | |
| +0.69% | +1.90% | +26.68% | -13.07% | 7.02TCr | |
| +0.82% | +3.84% | +50.84% | +155.14% | 1.23TCr | |
| -0.50% | +0.96% | -2.77% | -1.31% | 848.82Cr | |
| -2.31% | -3.32% | -14.66% | -1.06% | 489.03Cr | |
| -1.19% | -0.48% | -27.57% | +15.69% | 454.36Cr | |
| +1.34% | -29.39% | -24.38% | +6.91% | 303.71Cr | |
| +0.49% | -8.46% | +1.01% | +42.98% | 262.21Cr | |
| +2.75% | -3.82% | -14.32% | -6.50% | 204.73Cr | |
| Average | -0.20% | +1.23% | +8.63% | +26.70% | 5.33TCr | |
| Weighted average by Cap. | +3.30% | +8.71% | +68.67% | +34.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30L 35.01L 28.11L 25.68L 48.46L 33Cr 48.94L 3.32Cr 1.29Cr 17Cr 1.31Cr 1.29Cr 56Cr | 1Cr 1.17Cr 93.7L 85.59L 1.62Cr 111.26Cr 1.63Cr 11Cr 4.3Cr 56Cr 4.38Cr 4.29Cr 185.89Cr |
| Net income | -60L -70.02L -56.22L -51.35L -96.92L -67Cr -97.87L -6.63Cr -2.58Cr -34Cr -2.63Cr -2.57Cr -111.53Cr | 10L 11.67L 9L 9L 16.15L 11Cr 16.31L 1.11Cr 43.03L 5.61Cr 43.82L 42.86L 19Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
